VivoSim Labs, INC. cotiza a 0.17 USD y tiene una capitalización bursátil de $3M. En los últimos 12 meses ha facturado $112000 con un margen de flujo de caja libre del -8264.9%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models. The company also p…
| Periodo | 2025-02 | 2024-11 | 2024-08 | 2024-05 |
|---|---|---|---|---|
| Real | $-2.28 | $-1.68 | $-2.76 | $-8.04 |
| Estimado | $-2.40 | $-2.64 | $-3.96 | $-5.04 |
| Sorpresa | +5.0% | +36.4% | +30.3% | -59.5% |
| Métrica | VIVS | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 100.0% | 57.0% | +43.0% |
| Operating Margin | -8768.7% | -38.6% | -8730.1% |
| Net Margin | -10567.2% | -33.6% | -10533.6% |
| FCF Margin | -8264.9% | -13.9% | -8251.0% |
| ROE | — | -40.4% | — |
| ROA | -187.4% | -32.0% | -155.4% |
| Current Ratio | 2.38 | 2.84 | -0.46 |
| Debt / Equity | — | 0.28 | — |